You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure

  • Technology appraisal guidance
  • Reference number: TA617
  • Published:  08 January 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final draft guidance
  3. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 144 KB)

    Published:
    09 January 2020

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 257 KB)

    Published:
    22 November 2019
  • Committee papers (PDF 8.28 MB)

    Published:
    22 November 2019

Invitation to participate

  • Final scope (PDF 215 KB)

    Published:
    29 December 2018
  • Equality impact assessment (Scoping) (PDF 178 KB)

    Published:
    29 December 2018
  • Final stakeholder list (PDF 259 KB)

    Published:
    23 January 2019
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 572 KB)

    Published:
    23 January 2019
  • Final protocol (PDF 845 KB)

    Published:
    12 February 2019
Back to top